Novel frontiers in ultra-structural and molecular MRI of the brain

Current Opinion in Neurology

Volumn 24, Issue 4, 2011, Pages 386-393

  Duyn, Jeff H ^a   Koretsky, Alan P ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

brain; cellular imaging; cytoarchitecture; high field MRI; tract tracing

Indexed keywords

CHOLERA TOXIN B SUBUNIT; GADOLINIUM CHELATE;

BRAIN MAPPING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; NEUROANATOMICAL TRACT TRACING; NONHUMAN; OLFACTORY BULB; OUTCOME ASSESSMENT; REVIEW; SENSITIVITY AND SPECIFICITY; VISUAL CORTEX; WHITE MATTER;

BRAIN; CEREBROVASCULAR CIRCULATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING;

EID: 79960845206     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328348972a     Document Type: Review

References (121)

1. Young IR, Hall AS, Pallis CA, et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2:1063-1066. (Pubitemid 11026868)
2. Bydder GM, Steiner RE, Young IR, et al. Clinical NMR imaging of the brain: cases. AJR Am J Roentgenol 1982; 139:215-236.
3. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992; 89:212-216.
4. Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 1990; 14:68-78. (Pubitemid 20243866)
5. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4:469-480. (Pubitemid 37280168)
6. Lee JH, Koretsky AP. Manganese enhanced magnetic resonance imaging. Curr Pharm Biotechnol 2004; 5:529-537. (Pubitemid 39654850)
7. Long CM, Bulte JW. In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin Biol Ther 2009; 9:293-306.
8. Nucifora PG, Verma R, Lee SK, Melhem ER. Diffusion-tensor mr imaging and tractography: exploring brain microstructure and connectivity. Radiology 2007; 245:367-384. (Pubitemid 47612518)
9. Ostergaard L, Jonsdottir KY, Mouridsen K. Predicting tissue outcome in stroke: new approaches. Curr Opin Neurol 2009; 22:54-59.
10. Hua X, Lee S, Hibar DP, et al. Mapping Alzheimer's disease progression in 1309. MRI scans: power estimates for different inter-scan intervals. Neuroimage 2010; 51:63-75.
11. Friston KJ. Models of brain function in neuroimaging. Annu Rev Psychol 2005; 56:57-87. (Pubitemid 40300779)
12. Matthews PM, Honey GD, Bullmore ET. Applications of fMRI in translational medicine and clinical practice. Nat Rev Neurosci 2006; 7:732-744. (Pubitemid 44267497)
13. de Zwart JA, Ledden PJ, Kellman P, et al. Design of a sense-optimized highsensitivity MRI receive coil for brain imaging. Magn Reson Med 2002; 47:1218-1227. (Pubitemid 34587414)
14. Mugler JP 3rd, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MPRAGE). Magn Reson Med 1990; 15:152-157. (Pubitemid 20284023)
15. Van Essen DC, Lewis JW, Drury HA, et al. Mapping visual cortex in monkeys and humans using surface-based atlases. Vision Res 2001; 41:1359-1378. (Pubitemid 32367897)
16. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000; 11 (6 Pt 1):805-821.
17. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000; 97:11050-11055.
18. Lerch JP, Pruessner JC, Zijdenbos A, et al. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex 2005; 15:995-1001. (Pubitemid 40848068)
19. Van Gelderen P, Koretsky AP, de Zwart JA, Duyn JH. A simple B1 correction method for high resolution neuroimaging. In: Proceedings of the 14th scientific meeting ISMRM; 2006; Seattle, Washington. pp. 2355.
20. Brodmann K. Localization in the cerebral cortex. Leipzig: Barth-Verlag; 1909.
21. Vogt O. Myeloarchitecture of the parietal cortex. J Psychol Neurol 1911; 18:107-118.
22. Clark VP, Courchesne E, Grafe M. In vivo myeloarchitectonic analysis of human striate and extrastriate cortex using magnetic resonance imaging. Cereb Cortex 1992; 2:417-424.
23. Barbier EL, Marrett S, Danek A, et al. Imaging cortical anatomy by highresolution MR at 3.0T: detection of the stripe of gennari in visual area 17. Magn Reson Med 2002; 48:735-738.
24. Bridge H, Clare S, Jenkinson M, et al. Independent anatomical and functional measures of the V1/V2 boundary in human visual cortex. J Vis 2005; 5:93-102. (Pubitemid 41519238)
25. Bock NA, Kocharyan A, Liu JV, Silva AC. Visualizing the entire cortical myelination pattern in marmosets with magnetic resonance imaging. J Neurosci Methods 2009; 185:15-22.
26. Pfeuffer J, Merkle H, Beyerlein M, et al. Anatomical and functional MR imaging in the macaque monkey using a vertical large-bore 7 Tesla setup. Magn Reson Imaging 2004; 22:1343-1359. (Pubitemid 40221930)
27. Aoki I, Wu YJ, Silva AC, et al. In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage 2004; 22: 1046-1059. (Pubitemid 38829194)
28. Silva AC, Lee J, Wu CH, et al. Detection of cortical laminar architecture using manganese enhanced MRI. J Neurosci Meth 2008; 167:246-257. (Pubitemid 350235635)
29. Berkowitz BA, Roberts R, Goebel DJ, Luan H. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest Ophthalmol Vis Sci 2006; 47:2668-2674. (Pubitemid 351639856)
30. Chuang KH, Belluscio L, Koretsky AP. In vivo detection of individual glomeruli in the rodent olfactory bulb using manganese enhanced MRI. Neuroimage 2010; 49:1350-1356.
31. Duyn JH, van Gelderen P, Li TQ, et al. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci USA 2007; 104:11796-11801. (Pubitemid 47175092)
32. Marques JP, Van Der Zwaag W, Granziera C, et al. Cerebellar cortical layers: in vivo visualization with structural high-field-strength MR imaging. Radiology 2010; 254:942-948.
33. Fukunaga M, Li TQ, van Gelderen P, et al. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci USA 2010; 107:3834-3839.
34. Ge Y, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch Neurol 2008; 65:812-816. (Pubitemid 351831461)
35. Kerchner GA, Hess CP, Hammond-Rosenbluth KE, et al. Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7T MRI. Neurology 2010; 75:1381-1387.
36. Pohmann R, Budde J, Auerbach EJ, et al. Theoretical and experimental evaluation of continuous arterial spin labeling techniques. Magn Reson Med 2010; 63:438-446.
37. Madan N, Grant PE. New directions in clinical imaging of cortical dysplasias. Epilepsia 2009; 50 (Suppl 9):9-18.
38. Tallantyre EC, Morgan PS, Dixon JE, et al. 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging 2010; 32:971-977.
39. Abosch A, Yacoub E, Ugurbil K, Harel N. An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 Tesla. Neurosurgery 2010; 67:1745-1756; discussion 1756. Early clinical application of T2*-weighted imaging at 7 T demonstrating improved electrode placement for deep brain stimulation.
40. Benveniste H, Ma Y, Dhawan J, et al. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy. Ann N Y Acad Sci 2007; 1097:12-29. (Pubitemid 47084883)
41. Jack CR Jr, Marjanska M, Wengenack TM, et al. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Neuroscientist 2007; 13:38-48. (Pubitemid 46052752)
42. Laule C, Vavasour IM, Kolind SH, et al. Magnetic resonance imaging of myelin. Neurotherapeutics 2007; 4:460-484. (Pubitemid 46962414)
43. Hwang D, Kim DH, Du YP. In vivo multislice mapping of myelin water content using T2*decay. Neuroimage 2010; 52:198-204.
44. Deoni SC. Magnetic resonance relaxation and quantitative measurement in the brain. Methods Mol Biol 2011; 711:65-108.
45. van Gelderen P, de Zwart JA, Lee J, et al. Nonexponential T2*decay in white matter. Magn Reson Med 2011 [Epub ahead of print].
46. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994; 66:259-267. (Pubitemid 24016507)
47. Moseley ME, Cohen Y, Kucharczyk J, et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990; 176:439-445. (Pubitemid 20225133)
48. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991; 7:1-30.
49. Mori S, Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006; 51:527-539. (Pubitemid 44301829)
50. Honey CJ, Thivierge JP, Sporns O. Can structure predict function in the human brain? Neuroimage 2010; 52:766-776.
51. Wiggins CJ, Gudmundsdottir V, Le Bihan D, et al. Orientation dependence of white matter T2*contrast at 7T: a direct demonstration. Proc Soc Magn Magn Reson Med 2008; 237
52. Lee J, Shmueli K, Fukunaga M, et al. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc Natl Acad Sci USA 2010; 107:5130-5135.
53. Li TQ, Yao B, van Gelderen P, et al. Characterization of T2*heterogeneity in human brain white matter. Magn Reson Med 2009; 62:1652-1657.
54. Liu C. Susceptibility tensor imaging. Magn Reson Med 2010; 63:1471-1477.
55. He X, Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci USA 2009; 106:13558-13563.
56. Wharton S, Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple-and single-orientation methods. Neuroimage 2010; 53:515-525.
57. Pautler RG, Silva AC, Koretsky AP. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 1998; 40:740-748. (Pubitemid 28493653)
58. Van Der Linden A, Verhoye M, Van Meir V, et al. In vivo manganeseenhanced magnetic resonance imaging reveals connections and functional properties of the songbird vocal control system. Neuroscience 2002; 112:467-474. (Pubitemid 34607030)
59. Saleem KS, Pauls JM, Augath M, et al. Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron 2002; 34:685-700. (Pubitemid 34628733)
60. Zhang X, Bearer EL, Boulat B, et al. Altered neurocircuitry in the dopamine transporter knockout mouse brain. PLoS One 2010; 5:e11506. Neural tract tracing with manganese enhanced MRI demonstrates that altered circuitry in a dopamine transporter knockout mouse model can be efficiently detected.
61. Tucciarone J, Chuang KH, Dodd SJ, et al. Layer specific tracing of corticocortical and thalamocortical connectivity in the rodent using manganese enhanced MRI. Neuroimage 2009; 44:923-931.
62. Van Der Linden A, VanMeir V, Boumans T, et al. MRI in small brains displaying extensive plasticity. Trends Neurosci 2009; 32:257-266.
63. Van Der Zijden JP, Wu O, Van Der Toorn A, et al. Changes in neuronal connectivity after stroke in rats as studied by serial manganese-enhanced MRI. Neuroimage 2007; 34:1650-1657. (Pubitemid 46187075)
64. Pelled G, Bergman H, Ben-Hur T, Goelman, G. Manganese-enhanced MRI in a rat model of Parkinson's disease. J Magn Reson Imag 2007; 26:363-370.
65. Martirosyan NL, Bennett KM, Theodore N, Preul MC. Manganese-enhanced magnetic resonance imaging in experimental spinal cord injury: correlation between T1-weighted changes and Mn(2\+) concentrations. Neurosurgery 2010; 66:131-136.
66. Berkowitz BA, Roberts R, Oleske DA, et al. Quantitative mapping of ion channel regulation by visual cycle activity in rodent photoreceptors in vivo. Invest Ophthalmol Vis Sci 2009; 50:1880-1885.
67. Wu CW-H, Vasalatily O, Wu H, et al. Tracing neuroanatomical connections in-vivo using a novel MR-visualizable compound. Neuron 2011 28;70:29-243.
68. Summers PE, Jarosz JM, Markus H. MR angiography in cerebrovascular disease. Clin Radiol 2001; 56:437-456.
69. Deistung A, Rauscher A, Sedlacik J, et al. Theoretical considerations and experimental results. Magn Reson Med 2008; 60:1155-1168.
70. Kang CK, Park CA, Park CW, et al. Lenticulostriate arteries in chronic stroke patients visualised by 7 T magnetic resonance angiography. Int J Stroke 2010; 5:374-380.
71. Tallantyre EC, Brookes MJ, Dixon JE, et al. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008; 70:2076-2078.
72. Tallantyre EC, Morgan PS, Dixon JE, et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009; 44:491-494.
73. Li X, Rooney WD, Varallyay CG, et al. Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination. J Magn Reson 2010; 206:190-199.
74. Kidwell CS, Latour L, Saver JL, et al. Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis 2008; 25:338-343. (Pubitemid 351555857)
75. Uppal R, Ay I, Dai G, et al. Molecular MRI of intracranial thrombus in a rat ischemic stroke model. Stroke 2010; 41:1271-1277.
76. McAteer MA, Akhtar AM, von Zur Muhlen C, Choudhury RP. An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. Atherosclerosis 2010; 209:18-27.
77. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000; 143:79-87.
78. Zhang S, Winter P, Wu K, Sherry AD. A novel Europium(iii)-based MRI contrast agent. J Am Chem Soc 2001; 123:1517-1518. (Pubitemid 32167350)
79. Goffeney N, Bulte JW, Duyn J, et al. Sensitive NMR detection of cationicpolymer-based gene delivery systems using saturation transfer via proton exchange. J Am Chem Soc 2001; 123:8628-8629. (Pubitemid 32808097)
80. Zhou J, Tryggestad E, Wen Z, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 2011; 17:130-134.
81. Gilad AA, McMahon MT, Walczak P, et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol 2007; 25:217-219. (Pubitemid 46227121)
82. Prost RW. Magnetic resonance spectroscopy. Med Phys 2008; 35:4530-4544.
83. Day SE, Kettunen MI, Gallagher FA, et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med 2007; 13:1382-1387. (Pubitemid 350073590)
84. Mendonca Dias MH, Lauterbur PC. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn Reson Med 1986; 3:328-330. (Pubitemid 16112954)
85. Yeh TC, Zhang W, Ildstad ST, Ho C. Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn Reson Med 1993; 30:617-625. (Pubitemid 23317319)
86. Bulte JW, Zhang S, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 1999; 96:15256-15261. (Pubitemid 30019799)
87. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997; 7:258-263. (Pubitemid 28365670)
88. Weinstein JS, Varallyay CG, Dosa E, et al. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010; 30:15-35.
89. Curtis MA, Kam M, Nannmark U, et al. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 2007; 315:1243-1249. (Pubitemid 46364256)
90. Manganas LN, Zhang X, Li Y, et al. Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science 2007; 318:980-985. (Pubitemid 350098995)
91. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228:480-487. (Pubitemid 36910091)
92. Hoehn M, Kustermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002; 99:16267-16272. (Pubitemid 35462784)
93. Dodd SJ, Williams M, Suhan JP, et al. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999; 76 (1 Pt 1): 103-109. (Pubitemid 29202442)
94. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med 2006; 55:242-249. (Pubitemid 43238090)
95. Foster-Gareau P, Heyn C, Alejski A, Rutt BK. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 2003; 49:968-971. (Pubitemid 36523485)
96. Sumner JP, Shapiro EM, Maric D, et al. In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: quantification of labeled cell phenotype. Neuroimage 2009; 44:671-678.
97. Shapiro EM, Gonzalez-Perez O, Manuel Garcia-Verdugo J, et al. Magnetic resonance imaging of the migration of neuronal precursors generated in the adult rodent brain. Neuroimage 2006; 32:1150-1157. (Pubitemid 44278680)
98. Vreys R, Vande Velde G, Krylychkina O, et al. MRI visualization of endogenous neural progenitor cell migration along the RMS in the adult mouse brain: validation of various MPIO labeling strategies. Neuroimage 2010; 49:2094-2103.
99. Zabow G, Dodd SJ, Moreland J, Koretsky AP. The fabrication of uniform cylindrical nanoshells and their use as spectrally tunable MRI contrast agents. Nanotechnology 2009; 20:385301.
100. Zabow G, Dodd S, Moreland J, Koretsky A. Micro-engineered local field control for high-sensitivity multispectral MRI. Nature 2008; 453:1058-1063. (Pubitemid 351871738)
101. Bendszus M, Ladewig G, Jestaedt L, et al. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study. Brain 2008; 131 (Pt 9):2341-2352.
102. Shin J, Anisur RM, Ko MK, et al. Hollow manganese oxide nanoparticles as multifunctional agents for magneitc resonance imaging and drug delivery. Angew Chem Int Ed Engl 2009; 48:321-324.
103. Vittorio O, Duce SL, Pietrabissa A, Cuschieri A. Multiwall carbon nanotubes as MRI contrast agents for tracking stem cells. Nanotechnology 2011; 22:095706.
104. Bonetto F, Srinivas M, Heerschap A, et al. A novel (19)F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int J Cancer 2010 [Epub ahead of print].
105. Meng X, Seton HC, Lu LT, et al. Magnetic CoPt nanoparticles as MRI contrast agent for transplanted neural stem cells detection. Nanoscale 2011 3:977-984.
106. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005; 23:983-987. (Pubitemid 41114032)
107. Srinivas M, Turner MS, Janjic JM, et al. In vivo cytometry of antigen-specific T cells using 19F MRI. Magn Reson Med 2009; 62:747-753.
108. Wu YL, Ye Q, Ho C. Cellular and functional imaging of cardiac transplant rejection. Curr Cardiovasc Imaging Rep 2011; 4:50-62.
109. Jo SK, Hu X, Kobayashi H, et al. Detection of inflammation following renal ischemia by magnetic resonance imaging. Kidney Int 2003; 64:43-51. (Pubitemid 36714156)
110. Floris S, Blezer EL, Schreibelt G, et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 2004; 127 (Pt 3):616-627. (Pubitemid 38295477)
111. Stoll G, Bendszus M. New approaches to neuroimaging of central nervous system inflammation. Curr Opin Neurol 2010; 23:282-286.
112. Neuwelt EA, Varallyay CG, Manninger S, et al. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study. Neurosurgery 2007; 60:601-611 [discussion 611-602]. (Pubitemid 46581060)
113. Vellinga MM, Oude Engberink RD, Seewann A, et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 2008; 131 (Pt 3):800-807. (Pubitemid 351294725)
114. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn Reson Med 1995; 33:200-208.
115. Zhang F, Xie J, Liu G, et al. In vivo MRI tracking of cell invasion and migration in a rat glioma model. Mol Imaging Biol 2010 [Epub ahead of print].
116. Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N Engl J Med 2006; 355:2376-2378. (Pubitemid 44837805)
117. Callera F, de Melo CM. Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34\+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34\+ cells' migration into the injured site. Stem Cells Dev 2007; 16:461-466. (Pubitemid 47016231)
118. de Vries IJ, Lesterhuis WJ, Barentsz JO, et al.Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005; 23:1407-1413. (Pubitemid 41679393)
119. Mueller SG, Schuff N, Yaffe K, et al. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2010; 31:1339-1347.
120. Shapiro MG, Westmeyer GG, Romero PA, et al. Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine. Nat Biotechnol 2010; 28:264-270.
121. Jasanoff A. MRI contrast agents for functional molecular imaging of brain activity. Curr Opin Neurobiol 2007; 17:593-600.